CRYO-CELL INTERNATIONAL, INC. Increase (Decrease) in Other Operating Liabilities
CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Increase (Decrease) in Other Operating Liabilities of $0 for the 12-month period ending 2025-11-30, per its 10-K filed 2026-02-27.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-02-27
- CRYO-CELL INTERNATIONAL, INC. increase (decrease) in other operating liabilities for the quarter ending 2025-11-30 was $0.00.
- CRYO-CELL INTERNATIONAL, INC. increase (decrease) in other operating liabilities for the quarter ending 2025-08-31 was $0.00, a 100.00% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. increase (decrease) in other operating liabilities for the quarter ending 2025-05-31 was $0.00.
- CRYO-CELL INTERNATIONAL, INC. increase (decrease) in other operating liabilities for the quarter ending 2025-02-28 was $0.00.
- CRYO-CELL INTERNATIONAL, INC. increase (decrease) in other operating liabilities for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- CRYO-CELL INTERNATIONAL, INC. increase (decrease) in other operating liabilities for fiscal 2024 was $2.79K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2025-11-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 derived: sum of 3 quarters · filed 2026-02-27 | $0.00 10-K · filed 2026-02-27 |
| 2025-08-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-15 | $0.00 derived: sum of 2 quarters · filed 2025-10-15 | $0.00 10-Q · filed 2025-10-15 | -$1.03K derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-05-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-15 | $0.00 10-Q · filed 2025-07-15 | -$1.03K derived: sum of 3 quarters · filed 2026-02-27 | $11.67K derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-02-28 | $0.00 10-Q · filed 2025-04-14 | -$1.03K derived: sum of 2 quarters · filed 2026-02-27 | $11.67K derived: sum of 3 quarters · filed 2026-02-27 | $7.97K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-11-30 | -$1.03K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $11.67K derived: sum of 2 quarters · filed 2026-02-27 | $7.97K derived: sum of 3 quarters · filed 2026-02-27 | $2.79K 10-K · filed 2026-02-27 |
| 2024-08-31 | $12.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-15 | $9.01K derived: sum of 2 quarters · filed 2025-10-15 | $3.83K 10-Q · filed 2025-10-15 | |
| 2024-05-31 | -$3.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-15 | -$8.87K 10-Q · filed 2025-07-15 | ||
| 2024-02-29 | -$5.18K 10-Q · filed 2025-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |